Cytokinetics (STU:KK3A) Institutional Ownership : 68.57% (As of Sep. 21, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Cytokinetics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cytokinetics's institutional ownership is 68.57%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cytokinetics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cytokinetics's Float Percentage Of Total Shares Outstanding is 65.45%.

Cytokinetics Institutional Ownership Historical Data

The historical data trend for Cytokinetics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytokinetics Institutional Ownership Chart

Cytokinetics Historical Data

The historical data trend for Cytokinetics can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	89.90	87.47	85.29	83.86	81.37	79.71	78.57	71.37	70.97	68.57

Cytokinetics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Cytokinetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytokinetics Inc (STU:KK3A) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

CYTK:USA KK3A:Germany

Address

350 Oyster Point Boulevard, South San Francisco, CA, USA, 94080

Website

https://www.cytokinetics.com

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Cytokinetics Headlines

No Headlines